Daewoong Pharmaceutical Co. Ltd.
Daewoong Pharmaceutical Co. Ltd. operates in Diversified Metals & Mining.
Market Cap & Net Worth: Daewoong Pharmaceutical Co. Ltd. (069620)
Daewoong Pharmaceutical Co. Ltd. (KQ:069620) has a market capitalization of $1.06 Million (₩1.56 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #35880 globally and #2139 in its home market, demonstrating a -1.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Daewoong Pharmaceutical Co. Ltd.'s stock price ₩162200.00 by its total outstanding shares 9590 (9.59K).
Daewoong Pharmaceutical Co. Ltd. Market Cap History: 2015 to 2026
Daewoong Pharmaceutical Co. Ltd.'s market capitalization history from 2015 to 2026. Data shows growth from $448.50K to $1.06 Million (8.15% CAGR).
Daewoong Pharmaceutical Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Daewoong Pharmaceutical Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 069620 by Market Capitalization
Companies near Daewoong Pharmaceutical Co. Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to Daewoong Pharmaceutical Co. Ltd. by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2400 globally with a market cap of $6.13 Billion USD ( €5.98 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2412 globally with a market cap of $6.09 Billion USD ( €5.94 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2400 | BERKSHIRE HATH-A | BE:BRH | $6.13 Billion | €634500.00 |
| #2412 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.09 Billion | €638000.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
Daewoong Pharmaceutical Co. Ltd. Historical Marketcap From 2015 to 2026
Between 2015 and today, Daewoong Pharmaceutical Co. Ltd.'s market cap moved from $448.50K to $ 1.06 Million, with a yearly change of 8.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩1.06 Million | -5.86% |
| 2025 | ₩1.13 Million | +36.31% |
| 2024 | ₩827.87K | +8.22% |
| 2023 | ₩765.00K | -25.92% |
| 2022 | ₩1.03 Million | +7.51% |
| 2021 | ₩960.59K | -9.94% |
| 2020 | ₩1.07 Million | +20.47% |
| 2019 | ₩885.36K | -26.73% |
| 2018 | ₩1.21 Million | +14.98% |
| 2017 | ₩1.05 Million | +140.40% |
| 2016 | ₩437.14K | -2.53% |
| 2015 | ₩448.50K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Daewoong Pharmaceutical Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.06 Million USD |
| MoneyControl | $1.06 Million USD |
| MarketWatch | $1.06 Million USD |
| marketcap.company | $1.06 Million USD |
| Reuters | $1.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.